Sanofi execs split over approach to Bristol-Myers acquisition

03/26/2007 | Times (London) (subscription required), The

A potential $54 billion bid by Sanofi-Aventis for Bristol-Myers Squibb reportedly is being hobbled by a dispute among top Sanofi executives. Sanofi chairman Jean-Francois Dehecq is said to favor a transformational deal with Bristol-Myers, while CEO Gerard Le Fur emphasizes a focus on the group's internal drug R&D program.

View Full Article in:

Times (London) (subscription required), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY